were excluded if they had a history of malignancy (except for local skin cancer or in situ cervical carcinoma) or inflammatory granuloma, or if they had a life expectancy <12 months. Interventions: After obtaining an informed consent, the provider withdrew residual 2 mg/mL baclofen from the subject's implanted pump and replaced it with 3 mg/mL of Gablofen Ò . Dose adjustments were not allowed for the first 10 days, after which the dose was adjusted up to 2 mg/day. Main Outcome Measures: Incidence of catheter-tip granulomas as confirmed by Magnetic Resonance Imaging (MRI) with or without contrast or a CT scan (when MRI was contraindicated), as well as other treatment-emergent adverse events (TEAEs) reported in the study population. Results or Clinical Course: Of the 153 enrolled subjects (age range 4 -69 years old), 108 (70.6%) completed their 9-month follow-up at the time of this safety analysis. A total of 50 serious adverse events (SAEs) were reported in 29 subjects (19%), and 4 events in 3 subjects (2.0%) were reported to be related to the study medication. None of the reported SAEs were considered unexpected based on the safety profile of intrathecal baclofen. Among the 63.4% of study subjects who experienced at least one TEAE, 8.5% of adverse events were considered treatment-related by the investigator. Overall, seven subjects presented with clinical signs and symptoms suggestive of a granuloma. Results from MRI in 6 subjects and CT scan in one subject confirmed absence of any catheter-tip granulomas in all seven subjects. Discussion: Not applicable Conclusion: No confirmed masses or catheter tip granulomas were seen in subjects who were administered 3 mg/mL baclofen via intrathecal pump during the 9-month duration. The 3 mg/mL concentration of baclofen appears to be safe and well-tolerated in the study population.Poster 97
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.